Specificity of Good Manufacturing Practice (GMP) for Biomedical Cell Products


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The article describes special aspects of Good Manufacturing Practice (GMP) for biomedical cell products (BMCP) that imply high standards of aseptics throughout the entire productio process, strict requirements to donors and to the procedure of biomaterial isolation, guaranty of tracing BMCP products, defining processing procedures which allow to identify BMCP as minimally manipulated; continuous quality control and automation of the control process at all stages of manufacturing, which will ensure product release simultaneously with completion of technological operations.

作者简介

M. Tulina

Institute of Pharmacy and Translational Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

编辑信件的主要联系方式.
Email: mari_bel_90@mail.ru
俄罗斯联邦, Moscow

N. Pyatigorskaya

Institute of Pharmacy and Translational Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: mari_bel_90@mail.ru
俄罗斯联邦, Moscow


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2018
##common.cookie##